Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
319
-
Total 13F shares, excl. options
-
19.1M
-
Shares change
-
-95.7K
-
Total reported value, excl. options
-
$4.43B
-
Value change
-
-$63.7M
-
Put/Call ratio
-
1.62
-
Number of buys
-
144
-
Number of sells
-
-174
-
Price
-
$232.22
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q4 2018
385 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q4 2018.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 319 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.1M shares
.
Largest 10 shareholders include BlackRock Inc. (1.94M shares), Vanguard Group Inc (1.89M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (749K shares), AMERICAN CENTURY COMPANIES INC (688K shares), WELLS FARGO & COMPANY/MN (646K shares), ACADIAN ASSET MANAGEMENT LLC (619K shares), TimesSquare Capital Management, LLC (611K shares), LEVIN CAPITAL STRATEGIES, L.P. (569K shares), STATE STREET CORP (470K shares), and UBS ASSET MANAGEMENT AMERICAS INC (415K shares).
This table shows the top 319 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.